November 3, 2025: Ozempic Interferes With Medical Imaging Tests, Study Finds A study has found that taking Ozempic and other GLP-1 receptor agonists can cause issues with medical imaging tests (like PET scans)
Experimental models show that this dual activation can influence both the magnitude and temporal pattern of growth hormone signaling, providing a framework for studying receptor synergy and signal integration [6]
Oral chondroprotection with nutraceuticals made of chondroitin sulphate plus glucosamine sulphate in osteoarthritis
S., Rose, L., Hansen, T., Zacho, J., & Pieber, T
The emerging HRT + GLP-1 synergy : why pairing estrogen with GLP-1s can improve outcomes for some women
This cascade effect represents one of the most significant advantages of GLP-1 pathway support over traditional weight loss approaches